On differences between immunity and immunological memory

Current Opinion in Immunology

Volumn 14, Issue 4, 2002, Pages 523-536

  Zinkernagel, Rolf M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS VACCINE; ANTIGEN;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY TITER; B LYMPHOCYTE; CELL MATURATION; CELL SPECIFICITY; CELL TYPE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL MEMORY; LYMPHOCYTE ACTIVATION; MEMORY CELL; NONHUMAN; REVIEW; SPECIES DIFFERENCE; VIRUS INFECTION; ANIMAL; ANTIBODY PRODUCTION; CATTLE; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; MOUSE; NOMENCLATURE; PASSIVE IMMUNIZATION; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; B-LYMPHOCYTES; CATTLE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOLOGIC MEMORY; IMMUNOLOGIC TESTS; MICE; T-LYMPHOCYTES; TERMINOLOGY; VIRUS DISEASES;

EID: 0036668253     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00367-9     Document Type: Review

References (112)

1. Immune response in mice that lack the interferon-gamma receptor
2. On immunological memory
3. On immunological memory
4. Maternal antibodies, childhood infections and autoimmune diseases
5. Mousepox (infectious ectromelia of mice): A review
6. High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month-old and older infants
7. Epidemiology
8. The death and resurrection of tuberculosis
9. Resistance to intracellular infection
10. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity
11. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus (VSV)
12. The role of antibody concentration and avidity in antiviral protection
13. Lack of significant differences in association rates and affinities of antibodies from short-term and long-term responses to hen egg lysozyme
14. A study of avidity based on rabbit skin responses to Diphtheria toxin-antitoxin mixtures
15. Epitopes on protein antigens: Misconceptions and realities
16. What is missing in immunology to understand immunity?
17. Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: Analysis in a viral model
18. Rabies pathogenesis
19. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice
20. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: Distinct mechanisms of action in vivo
21. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity
22. Analysis of the kinetics of antiviral memory T help in vivo: Characterization of short-lived cross-reactive T help
23. The requirement of more than one antigenic determinant for immunogenicity
24. The carrier effect in the secondary response to hapten-protein conjugates. V. Use of antilymphocyte serum to deplete animals of helper cells
25. The regulatory influence of activated T cells on B cell responses to antigen
26. How many specific B cells are needed to protect against a virus?
27. B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice. I. Preferential utilisation of the CH-proximal VH gene family PC7183
28. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice
29. Ber immunität durch Vererbung und Säugung
30. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: Mother-to-baby transfer of humoral protection
31. Influence of maternal antibodies on vaccine responses: Inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice
32. Antigenic variation in malaria
33. Immunity to schistosomes: Progress towards vaccine
34. A filterable virus recovered from white mice
35. Studies on pathogenesis and immunity in lymphocytic choriomeningitis infection of the mouse
36. The biology of lymphocytic choriomeningitis infection: Virus induced immune disease
37. Lymphocytic choriomeningitis virus
38. The virology and immunobiology of lymphocytic choriomeningitis virus infection
39. Lifetime of plasma cells in the bone marrow
40. Bone marrow is a major site of long-term antibody production after acute viral infection
41. Humoral immunity due to long-lived plasma cells
42. Long-lived plasma cells: A mechanism for maintaining persistent antibody production
43. Persistence of tetanus antitoxin in man following active immunisation
44. Immunological memory against viruses
45. CD8+ T-cell memory to viruses
46. Immunological memory
47. Immunological memory
48. The cellular basis of immunologic memory
49. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis
50. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues
51. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells
52. Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera
53. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs
54. Lymphocytic choriomeningitis: Production of antibody by "tolerant" infected mice
55. Declining T cell immunity to influenza, 1983-82
56. Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen
57. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses
58. HLA restriction of cell-mediated lysis of influenza virus-infected human cells
59. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses
60. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
61. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
62. Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus
63. T-cell-mediated immunopathology in viral infections
64. Immunology taught by viruses
65. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1
66. A critical role for neutralizing antibody-producing B cells, CD4+ T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
67. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice
68. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
69. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
70. Immunological memory and protective immunity: Understanding their relation
71. Thanks for the memory
72. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
73. Fibroblasts as efficient antigen-presenting cells in lymphoid organs
74. On the role of antigen in maintaining cytotoxic T-cell memory
75. A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria
76. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease
77. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection
78. Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
79. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
80. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: Generation, characterization, and cross-reactivity with other arenaviruses
81. Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses
82. Control of early viral and bacterial distribution and disease by natural antibodies
83. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus
84. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells
85. Viral persistence in vivo through selection of neutralizing antibody-escape variants
86. T cell memory. Long-term persistence of virus-specific cytotoxic T cells
87. Cytotoxic T-cell memory without antigen
88. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte population in vivo and in vitro
89. Vaccination for disease
90. Vaccine development. Real and imagined dangers
91. Invasion, control and persistence of Leishmania parasites
92. The immunological basis of acquired cellular resistance
93. The behaviour of microbial parasites in relation to phagocytic cells in vitro and in vivo
94. The immunology of antituberculous immunity
95. Cellular immunity
96. Immunity to intracellular bacteria
97. Mechanisms of acquired resistance in mouse typhoid
98. Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis virus
99. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses
100. Attrition of T cell memory: Selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses
101. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure
102. Immunosuppression by lymphocytic choriomeningitis virus infection: Competent effector T and B cells but impaired antigen presentation
103. Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect
104. Variations in affinities of antibodies during the immune response
105. Somatic mutation and the maturation of immune response to 2-phenyl oxazolone
106. Immune surveillance against a solid tumor fails because of immunological ignorance